SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-18-018361
Filing Date
2018-03-16
Accepted
2018-03-16 17:20:04
Documents
83
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a18-1093_110k.htm 10-K 1981579
2 EX-21.1 a18-1093_1ex21d1.htm EX-21.1 1569
3 EX-23.1 a18-1093_1ex23d1.htm EX-23.1 5312
4 EX-31.1 a18-1093_1ex31d1.htm EX-31.1 11617
5 EX-31.2 a18-1093_1ex31d2.htm EX-31.2 11609
6 EX-32.1 a18-1093_1ex32d1.htm EX-32.1 5237
7 EX-32.2 a18-1093_1ex32d2.htm EX-32.2 5231
14 GRAPHIC g10931bui001.gif GRAPHIC 20324
  Complete submission text file 0001104659-18-018361.txt   8240930

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT stml-20171231.xml EX-101.INS 1899162
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20171231.xsd EX-101.SCH 59814
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20171231_cal.xml EX-101.CAL 57541
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20171231_def.xml EX-101.DEF 187797
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20171231_lab.xml EX-101.LAB 564479
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20171231_pre.xml EX-101.PRE 382033
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35619 | Film No.: 18696666
SIC: 2834 Pharmaceutical Preparations